{
    "root": "6499b998-74f4-43c3-b2b6-79ea40ab474f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Scopolamine Trandermal System",
    "value": "20240530",
    "ingredients": [
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "ISOPROPYL PALMITATE",
            "code": "8CRQ2TH63M"
        },
        {
            "name": "LIGHT MINERAL OIL",
            "code": "N6K5787QVP"
        },
        {
            "name": "POLYISOBUTYLENE (55000 MW)",
            "code": "TQ77WR8A02"
        },
        {
            "name": "POLYISOBUTYLENE (1100000 MW)",
            "code": "FLT10CH37X"
        },
        {
            "name": "SCOPOLAMINE",
            "code": "DL48G20X8X"
        }
    ],
    "indications": "scopolamine transdermal system indicated adults prevention : •nausea vomiting associated motion sickness •post-operative nausea vomiting ( ponv ) associated recovery anesthesia and/or opiate analgesia surgery .",
    "contraindications": "application removal ( 2.1 ) • scopolamine transdermal system delivers 1 mg scopolamine 3 days . • wear one transdermal system time . • cut transdermal system . • wash hands thoroughly application . • upon removal , fold used transdermal system half sticky side together , discard prevent accidental contact ingestion . recommended : • motion sickness : apply one transdermal system hairless area behind one ear least 4 hours antiemetic effect required 3 days . therapy 3 days required , remove first transdermal system apply new transdermal system behind ear . ( 2.2 ) • ponv : surgeries cesarean section , apply one transdermal system behind ear evening surgery remove 24 hours following surgery . ( 2.2 )",
    "warningsAndPrecautions": "scopolamine transdermal system 1 mg/3 days available following : carton 24 transdermal systems , packaged individual foil pouches . ndc : 63629-8450-1 single patch ndc : 63629-8450-2 store 20°c 25°c ( 68°f 77°f ) [ usp controlled room temperature ] . store pouch ( es ) upright position . bend roll pouch ( es ) . wash hands thoroughly soap water immediately handling transdermal system . upon removal , fold used transdermal system half sticky side together , discard household trash manner prevents accidental contact ingestion children , pets others [ ( 2.1 ) , ( 5.6 ) ] . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "scopolamine transdermal system contraindicated patients : •angle closure glaucoma . [ ( 5.1 ) ] •hypersensitivity scopolamine belladonna alkaloids ingredient component formulation delivery system . included rash generalized erythema [ ( 6.2 ) , description ( 11 ) ] .",
    "indications_original": "Scopolamine transdermal system is indicated in adults for prevention of:\n                  \n                     \n                        •nausea and vomiting associated with motion sickness\n                     \n                        •post-operative nausea and vomiting (PONV) associated with recovery from anesthesia and/or opiate analgesia and surgery       .",
    "contraindications_original": "Application and Removal ( 2.1 ) • Each scopolamine transdermal system delivers 1 mg of scopolamine over 3 days. • Only wear one transdermal system at a time. • Do not cut the transdermal system. • Wash hands thoroughly after application. • Upon removal, fold used transdermal system in half with sticky side together, and discard to prevent accidental contact or ingestion. Recommended Dosage : • Motion Sickness : Apply one transdermal system to the hairless area behind one ear at least 4 hours before antiemetic effect is required for use up to 3 days. If therapy for more than 3 days is required, remove the first transdermal system and apply a new transdermal system behind the other ear. ( 2.2 ) • PONV : For surgeries other than cesarean section, apply one transdermal system behind the ear the evening before surgery and remove 24 hours following surgery. ( 2.2 )",
    "warningsAndPrecautions_original": "Scopolamine Transdermal System 1 mg/3 days is available as the following:\n                  \n                  \n                     Carton of 24 transdermal systems, packaged into individual foil pouches. NDC: 63629-8450-1\n                     Single Patch NDC: 63629-8450-2\n                  \n                  Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature].\n                  Store pouch(es) in an upright position.\n                  Do not bend or roll pouch(es).\n                  Wash hands thoroughly with soap and water immediately after handling the transdermal system. Upon removal, fold the used transdermal system in half with the sticky side together, and discard in household trash in a manner that prevents accidental contact or ingestion by children, pets or others [see Dosage and Administration (2.1), Warnings and Precautions (5.6)].\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "Scopolamine transdermal system is contraindicated in patients with:\n                  \n                     \n                        •angle closure glaucoma.       [see Warnings and Precautions (5.1)]       \n                     \n                     \n                        •hypersensitivity to scopolamine or other belladonna alkaloids or to any ingredient or component in the formulation or delivery system. Reactions have included rash generalized and erythema       [see Adverse Reactions (         6.2), Description (         11)]       ."
}